Clinical Trial Update: L-carnitine in Modulating Pain and Inflammation in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing L-carnitine for modulating pain and inflammation in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN